11. November 2025
Making 15O-water PET practical
Three Core Elements.
One Defined Workflow.
-
P3The P3 system is designed to produce and prepare 15O-water near the PET scanner, using 15O-labelled gas from an on-site cyclotron.Learn more -
aQuantaQuant processes 15O-water PET data and provides quantitative myocardial blood flow outputs and visualizations for review.Learn more -
¹⁵O-water15O-water is widely recognized as a reference-standard tracer for absolute perfusion quantification.Learn more
From scientific standard to real-world readiness, MedTrace is building the clinical, regulatory, and operational foundation to provide the future clinical use of 15O-water PET.
Building the Foundation for Use
Clinical Experience
MedTrace systems are installed for investigational purposes at leading clinical and research institutions, supporting workflow learning, evidence generation, and practical experience with 15O-water PET.
Regulatory Progress
MedTrace is advancing regulatory activities in the U.S. and Europe, supported by clinical development, quality systems, and product-specific regulatory work.
Collaboration Network
MedTrace collaborates with hospitals, researchers, and imaging partners to support evaluation, workflow learning, and future development of 15O-water PET.
Newsroom
-
-
30. October 2025
Medtrace Announces Leadership Transition: Peter Juul Kristensen Appointed as the New CEO
-
25. August 2025
Experience MedTrace’s software, aQuant, at ASNC2025 in Orlando
-
12. June 2025
MedTrace CEO Steps Down as Company Enhances Strategic Focus on the United States
-
21. May 2025
Join Us at SNMMI 2025 to Experience MedTrace’s 15O-Water Technologies
-
12. May 2025
MedTrace Secures € 10 Million Investment to Accelerate Phase III Clinical Trial, Aiming for Completion in 2026